Receptors, Interleukin-1 Type I
"Receptors, Interleukin-1 Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.
| Descriptor ID |
D053573
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300.500
|
| Concept/Terms |
Receptors, Interleukin-1 Type I- Receptors, Interleukin-1 Type I
- Receptors, Interleukin 1 Type I
- CD121a Antigens
- Receptor Type I, Interleukin-1
- Receptor Type I, Interleukin 1
- Interleukin-1 Receptor Type I
- Interleukin 1 Receptor Type I
- Antigens, CDw121a
- CDw121a Antigens
- Interleukin-1 Receptors Type I
- Interleukin 1 Receptors Type I
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1 Type I".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1 Type I".
This graph shows the total number of publications written about "Receptors, Interleukin-1 Type I" by people in this website by year, and whether "Receptors, Interleukin-1 Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2018 | 3 | 4 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-1 Type I" by people in Profiles.
-
Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19. Cytokine. 2021 07; 143:155544.
-
Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression. Eur Respir J. 2018 12; 52(6).
-
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. J Am Coll Cardiol. 2018 09 04; 72(10):1081-1090.
-
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue. J Biol Chem. 2018 09 14; 293(37):14224-14236.
-
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med. 2018 06; 13(4):475-489.
-
Redefining the ancestral origins of the interleukin-1 superfamily. Nat Commun. 2018 03 20; 9(1):1156.
-
Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses. Immunity. 2018 03 20; 48(3):584-598.e5.
-
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. J Hepatol. 2018 05; 68(5):986-995.
-
The NLRP3 Inflammasome and IL-1ß Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis. PLoS Pathog. 2015 Sep; 11(9):e1005155.